Tag: Cancer

NIH researchers make progress toward Epstein-Barr virus vaccine

A research team led by scientists from NIH’s National Institute of Allergy and Infectious Diseases (NIAID) has determined how several antibodies induced by Epstein-Barr virus (EBV), a herpesvirus that causes infectious mononucleosis and is associated with certain cancers, block infection of cells grown in the laboratory.


With Antibody-Drug Combination, NIAID Scientists Improve Outcomes of Bone Marrow Transplants in Mice

In a new paper published February 6 in Nature Communications, researchers from NIAID and Harvard University describe a way to better prepare a recipient to tolerate bone marrow donation, using an antibody-drug conjugate that combines a cell-targeting antibody with a cell toxin, which the antibody carries as cargo.